NDC11 16714089101
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 16714-0891-01 | 16714-0891 |
| 16714-0891-1 | 16714-0891 |
| 16714-891-01 | 16714-891 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sumatriptan and Naproxen Sodium | SUMATRIPTAN AND NAPROXEN SODIUM | NorthStar RxLLC | 3f2ec27e-0e96-4028-a1fa-114e6d501464 | 2025-11-20 | Boxed warning, Warnings, Adverse reactions | 16714-891-01 16714-891 16714089101 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.